No idea how a sole US listing would work with current Shareholders.
If there is a move to find and partner with another Biotech with a near term product, it would want to be a US company. That might in fact solve the whole complexity of US listing.
BTA Price at posting:
80.0¢ Sentiment: Buy Disclosure: Held